CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer

Abstract

CD44 is highly expressed in gastric cancer and is an independent prognostic factor associated with immune invasion, which can be used as a candidate prognostic biomarker to determine the prognosis associated with gastric immune invasion.